Literature DB >> 21938017

The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART.

R Rajasuriar1, D R Booth, M Gouillou, T Spelman, I James, A Solomon, K Chua, G Stewart, S Deeks, D R Bangsberg, C Muzoora, P U Cameron, P Hunt, J Martin, S R Lewin.   

Abstract

We previously found an association between faster CD4+ T-cell recovery in HIV-infected patients receiving combination antiretroviral therapy (cART) and interleukin-7 receptor-α (IL-7Rα) haplotype-2 in a predominantly Caucasian cohort. This study aims to determine whether this association was also significant in Africans. Patients were recruited from the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort (n=352). We used survival analysis and linear mixed modelling (LMM) to determine factors associated with CD4 T-cell recovery. Eight IL-7Rα single-nucleotide polymorphisms (SNPs) were genotyped in both Africans and Caucasians (n=57). Soluble (s)IL-7Rα levels were measured by ELISA. In UARTO, IL-7Rα haplotype-2 was associated with slower CD4 T-cell recovery following cART by using survival analysis (P=0.020) and no association was found with LMM (P=0.958). The tagging-SNP for IL-7Rα haplotype-2 (rs6897932) was associated with decreased sIL-7Rα (P<0.001). The haplotypes for the IL-7Rα were significantly different in Africans and Caucasians. Using IL-7Rα genotypes we found slower CD4 T-cell recovery in UARTO patients was still associated with rs6897932 (P=0.009) and rs3194051 was associated with faster CD4 T-cell recovery (P=0.006). Unlike Caucasians, we did not demonstrate a significant association between IL-7Rα haplotype 2 and faster CD4 T-cell recovery in Africans. The IL-7Rα SNPs associated with CD4 T-cell recovery following cART differ in African and Caucasian cohorts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21938017     DOI: 10.1038/gene.2011.65

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  15 in total

Review 1.  IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?

Authors:  Christian Lundtoft; Julia Seyfarth; Marc Jacobsen
Journal:  Genes Immun       Date:  2020-01-13       Impact factor: 2.676

2.  Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients.

Authors:  M Guzmán-Fulgencio; J Berenguer; D Pineda-Tenor; M A Jiménez-Sousa; M García-Álvarez; T Aldámiz-Echevarria; A Carrero; C Diez; F Tejerina; S Vázquez; V Briz; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-19       Impact factor: 3.267

3.  The influence of interleukin-7 receptor α-chain haplotypes on outcome after allogeneic hematopoietic cell transplantation.

Authors:  B Broux; Z Shamim; T Wang; S Spellman; M Haagenson; P Stinissen; L P Ryder; K Müller; N Hellings
Journal:  Int J Immunogenet       Date:  2014-10-29       Impact factor: 1.466

4.  Responsiveness to IL-7 but not to IFN-α is diminished in CD4+ T cells from treated HIV infected patients who experience poor CD4+ T-cell recovery.

Authors:  Thao P Nguyen; Supriya Shukla; Robert Asaad; Michael L Freeman; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

5.  Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.

Authors:  Yean K Yong; Esaki M Shankar; Ajantha Solomon; Tim Spelman; Christopher K Fairley; Julian H Elliott; Jennifer Hoy; Paul U Cameron; Adeeba Kamarulzaman; Sharon R Lewin
Journal:  AIDS       Date:  2016-09-10       Impact factor: 4.177

6.  Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.

Authors:  María Guzmán-Fulgencio; Juan Berenguer; María A Jiménez-Sousa; Daniel Pineda-Tenor; Teresa Aldámiz-Echevarria; Pilar García-Broncano; Ana Carrero; Mónica García-Álvarez; Francisco Tejerina; Cristina Diez; Sonia Vazquez-Morón; Salvador Resino
Journal:  J Transl Med       Date:  2015-06-30       Impact factor: 5.531

7.  P2X7 Receptor Inhibition Improves CD34 T-Cell Differentiation in HIV-Infected Immunological Nonresponders on c-ART.

Authors:  Inna Menkova-Garnier; Hakim Hocini; Emile Foucat; Pascaline Tisserand; Laure Bourdery; Constance Delaugerre; Clarisse Benne; Yves Lévy; Jean-Daniel Lelièvre
Journal:  PLoS Pathog       Date:  2016-04-15       Impact factor: 6.823

8.  Investigating Factors Associated with Thymic Regeneration after Chemotherapy in Patients with Lymphoma.

Authors:  Dao-Ping Sun; Li Wang; Chong-Yang Ding; Jin-Hua Liang; Hua-Yuan Zhu; Yu-Jie Wu; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

9.  Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis.

Authors:  Christian Lundtoft; Anthony Afum-Adjei Awuah; Jens Rimpler; Kirstin Harling; Norman Nausch; Malte Kohns; Ernest Adankwah; Franziska Lang; Laura Olbrich; Ertan Mayatepek; Ellis Owusu-Dabo; Marc Jacobsen
Journal:  PLoS Pathog       Date:  2017-06-05       Impact factor: 6.823

10.  The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.

Authors:  María Ángeles Jiménez-Sousa; Ana Zaida Gómez-Moreno; Daniel Pineda-Tenor; Luz Maria Medrano; Juan José Sánchez-Ruano; Amanda Fernández-Rodríguez; Tomas Artaza-Varasa; José Saura-Montalbán; Sonia Vázquez-Morón; Pablo Ryan; Salvador Resino
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.